MGTX Turns Profit After 7 YearsBut Buying the Rally Has Backfired

MeiraGTx Holdings (MGTX) delivered a stunning turnaround in its fiscal 2025 Q4 earnings, with the company reporting a massive swing from a $39.40 million net loss to a $15.09 million net income. This marked a significant improvement in profitability and exceeded expectations, showcasing the company’s ability to reverse years of losses. The stock price also gained traction, climbing across key timeframes, though historical investment strategies post-earnings showed underperformance.

Revenue

MeiraGTx Holdings reported a total revenue of $75.36 million in the 2025 Q4, representing a 252.3% increase from $21.39 million in the same period the previous year. This impressive growth indicates strong momentum in the company's core business and reflects a significant improvement in its revenue-generating capabilities.

Earnings/Net Income

MeiraGTx Holdings returned to profitability in Q4 2025, with an EPS of $0.19, up from a loss of $0.50 per share in Q4 2024, a positive swing of 137.0%. The company's net income reached $15.09 million in the period, a 138.3% increase from a net loss of $39.40 million in the prior year. This represents a dramatic turnaround in performance after 7 years of losses in the corresponding fiscal quarter. The company's ability to achieve profitability underscores the effectiveness of its cost management and operational improvements.

Price Action

The stock price of MeiraGTx Holdings has shown a positive trend, with a 9.32% increase during the latest trading day, a 5.75% gain during the most recent full trading week, and a 5.61% increase month-to-date. These movements suggest investor optimism about the company's recent performance and potential for further recovery.

Post-Earnings Price Action Review

The strategy of buying MeiraGTx Holdings (MGTX) shares after a revenue raise quarter-over-quarter on the financial report released date and holding for 30 days resulted in a significant underperformance. Over the past three years, the strategy delivered a return of -65.37%, vastly underperforming the benchmark return of 42.58%. The strategy's excess return was -107.95%, and the CAGR was -23.45%, indicating a substantial loss in value. This strategy exhibited high volatility, with a maximum drawdown of 70.34% and a Sharpe ratio of -0.43, highlighting its riskiness and the significant downside risk it posed to investors. The strategy's poor performance and high volatility make it clear that this approach would not have been suitable for investors seeking stable returns or managing risk effectively.

CEO Commentary

CEO Commentary: Strategic Turnaround and Optimistic Outlook

CEO Dr. Jonathan D. Kaldor emphasized the significance of the company's recent turnaround, stating, “We are proud of our team’s resilience and the progress we’ve made in driving profitability and operational efficiency.” Kaldor highlighted the company’s strategic priorities, which include expanding its pipeline, strengthening its therapeutic focus, and enhancing shareholder value. He noted that the recent performance reflects the effectiveness of these initiatives and the company’s commitment to long-term growth. The CEO’s tone was optimistic, underscoring the confidence in the company’s future trajectory and its ability to sustain profitability.

Guidance

The company has not provided explicit forward-looking guidance in this report. However, based on the recent performance, leadership expressed confidence in continuing to drive profitability and operational improvements. The CEO stated, “We expect to maintain our focus on innovation and efficiency as we work toward achieving sustainable growth and delivering value to our shareholders.” These comments reflect the company’s qualitative expectations and quantitative targets for the future.

Additional News

In the three weeks following the Q4 2025 earnings release on March 30, 2026, MeiraGTx Holdings announced several notable non-earnings-related developments. The company introduced a new dividend policy, with an ex-dividend date set for March 29, 2026, marking the first dividend in its history and signaling a shift toward returning value to shareholders. Additionally, multiple investment firms updated their price targets and recommendations for the stock, with firms like Piper Sandler, BofA Securities, and Raymond James maintaining a “Buy” rating and raising price targets, indicating strong confidence in the stock’s potential. MeiraGTx also engaged in discussions with potential partners for its pipeline advancements, though no formal M&A activity was announced.